TONI, Giulia
 Distribuzione geografica
Continente #
EU - Europa 16.032
NA - Nord America 6.258
AS - Asia 3.466
SA - Sud America 539
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 82
OC - Oceania 20
AN - Antartide 2
Totale 26.612
Nazione #
IT - Italia 13.405
US - Stati Uniti d'America 6.070
SG - Singapore 1.217
CN - Cina 852
NL - Olanda 574
DE - Germania 473
BR - Brasile 421
FR - Francia 361
VN - Vietnam 357
UA - Ucraina 323
HK - Hong Kong 259
TR - Turchia 215
GB - Regno Unito 193
FI - Finlandia 167
BD - Bangladesh 126
IN - India 105
RU - Federazione Russa 93
CA - Canada 88
JP - Giappone 79
CH - Svizzera 75
SE - Svezia 70
MX - Messico 63
ES - Italia 56
PL - Polonia 51
ID - Indonesia 45
AR - Argentina 36
BE - Belgio 29
IQ - Iraq 24
TH - Thailandia 21
CO - Colombia 19
RO - Romania 19
ZA - Sudafrica 19
AU - Australia 18
EC - Ecuador 18
AT - Austria 15
MY - Malesia 15
DK - Danimarca 14
IR - Iran 14
KR - Corea 14
LT - Lituania 14
MA - Marocco 14
PH - Filippine 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
CZ - Repubblica Ceca 13
IE - Irlanda 13
PK - Pakistan 13
UZ - Uzbekistan 13
GR - Grecia 12
IL - Israele 12
SA - Arabia Saudita 12
BO - Bolivia 10
VE - Venezuela 10
JM - Giamaica 9
TW - Taiwan 8
AL - Albania 7
KE - Kenya 7
PT - Portogallo 7
TN - Tunisia 7
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
MT - Malta 6
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
NO - Norvegia 5
PE - Perù 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CR - Costa Rica 4
MD - Moldavia 4
NP - Nepal 4
OM - Oman 4
UY - Uruguay 4
AO - Angola 3
CI - Costa d'Avorio 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HR - Croazia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
PA - Panama 3
PR - Porto Rico 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
SM - San Marino 3
TT - Trinidad e Tobago 3
AQ - Antartide 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
LY - Libia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
Totale 26.375
Città #
Milan 1.105
Rome 822
Singapore 751
Ashburn 631
San Jose 547
Fairfield 372
Woodbridge 319
Beijing 304
Santa Clara 282
Chandler 271
Jacksonville 264
Dallas 262
Hong Kong 249
Naples 228
Houston 211
Turin 204
Bologna 189
Council Bluffs 175
Florence 168
Ann Arbor 163
Seattle 156
Munich 153
Wilmington 149
Bari 140
Cambridge 136
Palermo 131
Izmir 123
Ho Chi Minh City 114
Brescia 111
Hanoi 101
Los Angeles 98
Helsinki 96
Ferrara 93
New York 93
Catania 86
Genoa 83
Verona 81
Nanjing 80
Tokyo 75
Bremen 65
Padova 65
Princeton 63
Lauterbourg 60
Modena 60
Perugia 60
Redwood City 60
Cagliari 58
Parma 54
Dearborn 51
Bergamo 49
Shanghai 46
Boardman 45
Reggio Emilia 40
The Dalles 39
Trieste 39
Chicago 38
São Paulo 38
Pescara 37
Venice 36
Trento 35
Monza 32
Orem 32
Salerno 32
Toronto 32
Falkenstein 31
Mexico City 30
Treviso 30
Pisa 29
San Diego 29
London 28
Napoli 28
Tianjin 27
Rimini 26
Amsterdam 25
Lucca 24
Mountain View 23
Warsaw 23
Washington 23
Nanchang 22
Taranto 22
Bolzano 21
Chennai 21
Moscow 21
Shenyang 20
Torino 20
Jiaxing 19
Phoenix 19
Afragola 18
Montreal 18
Novara 18
Reggio Calabria 18
Vicenza 18
Boston 17
Cinisello Balsamo 17
Jakarta 17
Lamezia Terme 17
Livorno 17
Manchester 17
San Francisco 17
Sassari 17
Totale 11.569
Nome #
Ustioni da airbag: una problematica emergente 10.984
Maintenance therapy: A crucial strategy in acne treatment 1.582
Linfangioma circoscritto vulvare: quando le cose si complicano. 1.049
Cinquanta sfumature di blu. 605
Anti-infiammatori non steroidei nell’acne: quale razionale? 561
Possibili marcatori di malattia e prognosi nel lichen sclerosus vulvare: il contributo dell’epigenetica. 442
Clobetasol propionate vs. mometasone furoate in 1-year proactive maintenance therapy of vulvar lichen sclerosus: Results from a comparative trial 418
Anatomia e fisiologia dell’unità pilo-sebacea 328
null 309
Effect of Corticosteroid Phobia on Treatment Adherence and Outcome in Women With Lichen Sclerosus: A Prospective Study 281
Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature. 241
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients. 235
Level of use and safety of botanical products for itching vulvar dermatoses. Are patch tests useful? 229
Insect repellents and contact sensitization: An observational study 229
Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline. 225
Side-effects of tango: Connubial contact dermatitis 216
Dermoscopy of patch test reactions: study of applicability in differential diagnosis between allergic and irritant reactions 214
Clinical and dermoscopic changes of vulvar lichen sclerosus after topical corticosteroid treatment 212
Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: Results of efficacy and tolerability 209
Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera? 206
Combining topical tretinoin with mometasone furoate in the treatment of vulvar lichen sclerosus: Results of dermoscopic assessment 193
Efficacy and safety of a 12-month treatment with a combination of hydroxypinacolone retinoate and retinol glycospheres as maintenance therapy in acne patients after oral isotretinoin 190
Topical Corticosteroid Phobia Among Women Affected With Vulvar Lichen Sclerosus: Results From a Cross-sectional Survey 188
Hidradenitis Suppurativa: The Effect Of Combinated Treatment With Oral Clindamycin And Rifampicin 185
Adapalene 0.1% / benzoyl peroxide 2.5% gel fixed combination after oral isotretinoin: evaluation of acne recurrence incidence. 184
Severe vulvovaginal allergic contact dermatitis due to clotrimazole contained in multiple topical products 184
Combined therapy in vulvar lichen sclerosus: does topical tretinoin improve the efficacy of mometasone furoate? 184
Aromatherapy and occupational allergic contact dermatitis: Two further cases caused by lavender oil and other essential oils 182
Acne e retinoidi: come e quando impiegarli. 180
An update on hidradenitis suppurativa treatment. 178
Systemic allergic dermatitis due to gentamicin 178
Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment? 174
I corticosteroidi sistemici nell’acne: perché, quando, come. 168
Consensus conference su isotretinoina orale. 166
Low-cumulative dose isotretinoin treatment in mild to moderate acne. 163
Cortisonici a confronto. 161
Cryogenic burn by cryolipolysis [Ustione a frigore da criolipolisi] 161
Plasma cell vulvitis: further confirmation of the diagnostic utility of dermoscopy 161
Acne meccanica da tutore ortopedico. 158
Mammary pigmented Paget's disease in a male: A diagnostic challenge 155
La biopsia del corneo nello studio dei comedoni. 154
Bullous irritant contact dermatitis caused by an alcoholic extract from Juglans regia leaves 154
What’s new in acne? New therapeutic approaches. 152
Prospective clinical and epidemiologic study of vulvar lichen sclerosus: analysis of prevalence and severity of clinical features, together with historical and demographic associations. 151
Patch test reactions through the lens of dermoscopy: Further insights, particularly on weak allergic reactions 151
null 149
Radiation-induced angiosarcoma of the breast: an uncommon polymorphic disorder 146
Proposal for post-acne scar management algorithm. 145
Cheiliti da contatto 145
Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study 144
It looks like acne, but… 141
Effectiveness of silk fabric underwear as an adjuvant tool in the management of vulvar lichen simplex chronicus: results of a double-blind randomized controlled trial 140
What treatments are on the horizon for acne. 135
Rosacea Fulminans. 135
Topical treatment of acne: immunomodulatory approaches. 132
Maintenance therapy in acne 132
Does Clearance of Vulvar Lichen Sclerosus after a Corticosteroid Treatment Correspond to a Decrease in Disease-Related Burden? Results from a Cohort Study Using Pictorial Representation of Illness and Self-Measure and the Dermatology Life Quality Index 127
Umbilical nodules: Two cases of atypical cutaneous endometriosis 122
Micosi profonda ed iperplasia pseudolinfomatosa. 121
Successful treatment of ectropion induced by actinic keratoses with photodynamic therapy: Report of two cases 118
Dermoscopy of vulvar multiple syringomas: a diagnostic aid for a rare entity 117
Hidradenitis suppurativa: medical and surgical therapy review. 117
Pioderma gangrenoso recidivante del volto trattato con dapsone. 117
Lichen sclerosus vulvare: caratteristiche clinico-epidemiologiche, fattori di rischio ed elementi prognostici in pazienti seguite c/o l’ambulatorio di patologia vulvare. 115
Proposal of a self-assessment questionnaire for the diagnosis of sensitive skin 113
null 112
When traditional Chinese medicine runs on WhatsApp® 110
Paget mammario pigmentato 105
Continuous vs. tapering application of the potent topical corticosteroid mometasone furoate in the treatment of vulvar lichen sclerosus: Results of a randomized trial 105
Searching for a “Window of Opportunity” in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment 97
null 95
Dermoscopy in plasma cell balanitis: its usefulness in diagnosis and follow-up. 94
Real-World Safety of Oral Isotretinoin in Patients During Sunny Months: Retrospective Cohort Study 91
null 83
Onychomadesis following hand, foot, and mouth disease: a case report from Italy and review of the literature. 79
Totale 26.612
Categoria #
all - tutte 70.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 942
Totale 71.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.402 0 0 135 151 129 81 115 94 90 147 141 319
2022/20232.570 223 188 126 191 237 208 184 165 229 177 271 371
2023/20243.792 352 395 329 291 245 279 234 235 189 349 443 451
2024/20255.051 539 500 458 291 495 406 316 352 505 423 392 374
2025/20266.662 620 381 615 664 840 478 735 400 531 731 321 346
2026/20271.195 303 544 348 0 0 0 0 0 0 0 0 0
Totale 26.612